Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

DPP7 Inhibitors

Dipeptidyl peptidase 7, abbreviated as DPP7, belongs to a class of enzymes known as dipeptidyl peptidases (DPPs) that play crucial roles in the regulation of peptide metabolism and homeostasis within the human body. DPP7 is an exopeptidase, which means it cleaves dipeptides from the N-terminus of various peptide substrates. Structurally, DPP7 is a member of the S46 family of serine proteases and is characterized by the presence of a catalytic triad consisting of serine, aspartate, and histidine residues, which is essential for its enzymatic activity. DPP7 is primarily found in the cytoplasm of cells, with particularly high expression in immune cells such as lymphocytes and monocytes, as well as in the gastrointestinal tract and various other tissues. This enzyme is involved in the degradation and regulation of peptides, playing a critical role in the modulation of peptide signaling and immune responses. DPP7 specifically targets dipeptides with proline or alanine at the N-terminus, cleaving them to release free amino acids. By doing so, DPP7 helps maintain peptide homeostasis by inhibiting the accumulation of bioactive peptides that could influence cellular processes. Additionally, DPP7's activity can influence the bioavailability and activity of peptides involved in immune regulation, cell signaling, and other physiological processes. Its role in peptide metabolism highlights the importance of DPP7 in maintaining cellular and systemic balance, although further research is needed to fully elucidate its functions and regulatory mechanisms.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

A 68930 hydrochloride

130465-39-3sc-203485
sc-203485A
10 mg
50 mg
$176.00
$733.00
2
(0)

A-68930 is a DPP7 inhibitor with a mechanism that likely involves binding to the active site of the enzyme. This binding inhibits the proteolytic activity of DPP7, affecting its role in peptide metabolism and potentially impacting immune responses.

Vildagliptin

274901-16-5sc-208485
10 mg
$176.00
4
(1)

Vildagliptin is a DPP-4 inhibitor with potential DPP7 inhibitory activity. Its mechanism involves blocking the degradation of incretin hormones, which can enhance insulin secretion. While its DPP7 inhibition is less pronounced, it may affect peptide metabolism to some extent.

Diprotin A

90614-48-5sc-497890
5 mg
$292.00
(0)

Diprotin A is a tripeptide aldehyde that acts as a competitive inhibitor of DPP7. By binding to the enzyme's active site, it hinders substrate binding and cleavage, potentially influencing the degradation of specific peptides and immune responses.

Canagliflozin

842133-18-0sc-364454
sc-364454A
5 mg
50 mg
$312.00
$416.00
2
(0)

TA-7284 is a DPP7 inhibitor that likely binds to the enzyme's active site. This binding interferes with DPP7's proteolytic activity, impacting the degradation of certain peptides and potentially modulating immune responses and other related processes.

Dipeptidylpeptidase IV Inhibitor IV, K579

440100-64-1sc-202583
5 mg
$235.00
3
(0)

K-579 is a small molecule inhibitor of DPP7 that likely functions by binding to the enzyme's active site. By inhibiting DPP7's enzymatic activity, it may influence the degradation of specific peptides and their roles in immune regulation and inflammation.

Dapagliflozin

461432-26-8sc-364481
sc-364481A
sc-364481B
5 mg
50 mg
1 g
$117.00
$428.00
$1051.00
6
(1)

Dapagliflozin may have off-target effects on DPP7 due to structural similarities. Its mechanism involves reducing glucose reabsorption in the kidneys but may impact DPP7-related processes to some extent.